文献速递主动脉外科瓣膜外科

保留瓣膜的再植入技术治疗主动脉瘤与主动脉瓣反流的长期经验

Long-term experience with valve-sparing reimplantation technique for the treatment of aortic aneurysm and aortic regurgitation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-11-26

该研究回顾了1999至2017年间440例接受保留瓣膜再植入技术的连续患者,分析其长期结局。结果显示院内死亡率为0.7%,10年生存率为79.7%±3.8%,10年免于瓣膜再手术率为89.6%±2.9%,瓣膜相关并发症发生率低,且在单纯主动脉瓣反流患者及不同瓣膜表型中耐久性相似。

要点

  • 保留瓣膜再植入技术围术期死亡率低(0.7%)。
  • 10年生存率79.7%±3.8%,10年免于再手术率89.6%±2.9%。
  • 瓣膜相关并发症线性发生率低,且在不同适应症和瓣膜表型间耐久性相似。

核心结论

  • 保留瓣膜再植入技术围术期死亡率低,瓣膜相关并发症发生率极低,长期耐久性优异。
  • 该技术可安全用于单纯主动脉瓣反流患者,且瓣膜修复耐久性不受手术适应症或瓣膜表型影响。

研究设计与样本

  • 单中心回顾性队列研究,纳入1999年至2017年间440例连续接受保留瓣膜再植入技术的患者,平均年龄49±15岁。
  • 采用Kaplan-Meier法进行时间-事件分析,Cox比例风险模型探索晚期结局的显著预测因素。

主要发现

  • 院内死亡率为0.7%(n=3)。
  • 大出血、血栓栓塞事件和感染性心内膜炎的线性发生率分别为0.37%、0.73%和0.2%患者-年。
  • 19例需晚期主动脉瓣再手术,10年免于瓣膜再手术率为89.6%±2.9%,组间及三叶瓣与二叶瓣表型间无显著差异。

临床怎么用

  • 对于主动脉根部瘤、瘤伴显著主动脉瓣反流或单纯主动脉瓣反流患者,保留瓣膜再植入技术可作为安全有效的治疗选择。
  • 该技术长期耐久性良好,瓣膜相关并发症风险低,适用于不同瓣膜表型患者。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze our long-term experience with valve-sparing reimplantation technique for the treatment of isolated root aneurysm, aneurysm with significant aortic regurgitation, and for isolated aortic regurgitation. METHODS: Between 1999 and 2017, 440 consecutive patients underwent valve-sparing reimplantation in our institution. The mean age of this cohort was 49 ± 15 years. Time-to-event analysis was performed with the Kaplan-Meier method, whereas significant predictors of late outcomes were explored with Cox proportional hazard model. RESULTS: In-hospital mortality was 0.7% (n = 3). Four hundred fourteen patients were available for long-term analysis. Median duration of follow-up was 5 years (interquartile range, 2-8.5 years). Thirty-six patients (8.5%) died during follow-up; therefore, survival was 79.7% ± 3.8% at 10 years. During follow-up we observed a linearized rate of 0.37%, 0.73%, and 0.2% patient-year, respectively, for major bleeding, thromboembolic events, and infective endocarditis. Nineteen patients required late aortic valve reoperation and freedom from valve reoperation was 89.6% ± 2.9% at 10 years and was not significantly different between groups or between tricuspid or bicuspid valve phenotypes. CONCLUSIONS: Our study shows that valve-sparing reimplantation is associated with low perioperative mortality, a remarkably low rate of valve-related complications, and excellent long-term durability. Further, it can be safely performed also in patients with isolated aortic regurgitation and the durability of valve repair is similar regardless of the indication for surgery of valve phenotype.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Mastrobuoni S, de Kerchove L, Navarra E, et al. Long-term experience with valve-sparing reimplantation technique for the treatment of aortic aneurysm and aortic regurgitation. J Thorac Cardiovasc Surg. 2018. PMID: 30635185. doi:10.1016/j.jtcvs.2018.10.155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。